Repligen Corp (RGEN)
167.32
+0.27
(+0.16%)
USD |
NASDAQ |
May 06, 13:11
Repligen Cash from Investing (Quarterly): -8.362M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -8.362M |
| December 31, 2023 | -169.90M |
| September 30, 2023 | -8.77M |
| June 30, 2023 | 64.83M |
| March 31, 2023 | -9.433M |
| December 31, 2022 | -121.31M |
| September 30, 2022 | -57.49M |
| June 30, 2022 | -26.22M |
| March 31, 2022 | -28.21M |
| December 31, 2021 | -62.28M |
| September 30, 2021 | -132.70M |
| June 30, 2021 | -17.20M |
| March 31, 2021 | -8.997M |
| December 31, 2020 | -158.29M |
| September 30, 2020 | -33.58M |
| June 30, 2020 | -4.48M |
| March 31, 2020 | -5.037M |
| December 31, 2019 | -7.111M |
| September 30, 2019 | -6.892M |
| June 30, 2019 | -187.48M |
| March 31, 2019 | -3.828M |
| December 31, 2018 | -5.457M |
| September 30, 2018 | -4.168M |
| June 30, 2018 | -2.848M |
| March 31, 2018 | -1.564M |
| Date | Value |
|---|---|
| December 31, 2017 | -1.621M |
| September 30, 2017 | -111.21M |
| June 30, 2017 | 8.055M |
| March 31, 2017 | 6.077M |
| December 31, 2016 | -35.32M |
| September 30, 2016 | -13.90M |
| June 30, 2016 | -1.18M |
| March 31, 2016 | 1.20M |
| December 31, 2015 | 2.672M |
| September 30, 2015 | 1.616M |
| June 30, 2015 | 0.224M |
| March 31, 2015 | 0.279M |
| December 31, 2014 | -1.223M |
| September 30, 2014 | -1.716M |
| June 30, 2014 | -17.81M |
| March 31, 2014 | 0.9616M |
| December 31, 2013 | -10.03M |
| September 30, 2013 | -2.069M |
| June 30, 2013 | -0.7617M |
| March 31, 2013 | -5.049M |
| December 31, 2012 | 3.140M |
| September 30, 2012 | -1.292M |
| June 30, 2012 | 1.379M |
| March 31, 2012 | -0.3859M |
| September 30, 2011 | 3.216M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-187.48M
Minimum
Jun 2019
64.83M
Maximum
Jun 2023
-49.45M
Average
-21.71M
Median
Cash from Investing (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -0.089M |
| Retractable Technologies Inc | -0.3478M |
| Xtant Medical Holdings Inc | -2.313M |
| Asensus Surgical Inc | 7.427M |
| Catheter Precision Inc | -0.018M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 44.71M |
| Cash from Financing (Quarterly) | -8.974M |
| Free Cash Flow | 109.54M |
| Free Cash Flow Per Share (Quarterly) | 0.6427 |
| Free Cash Flow to Equity (Quarterly) | 32.53M |
| Free Cash Flow to Firm (Quarterly) | 41.66M |
| Free Cash Flow Yield | 1.16% |